VC  Foresite Capital

     Office Locations:

600 Montgomery Street
Suite 4500
San Francisco, CA 94111
Phone: 415-877-4887
Fax: 415-567-0091

Get all office locations for this firm with a National Database subscription or New York Database subscription.


  • Expansion



  • Life Sciences & Healthcare
  • Medical Device



    Foresite Capital invests between $10 million and $50 million per investment in emerging healthcare companies with disruptive late-stage products with large market opportunities in therapeutics, devices, diagnostics, and services. Since inception in 2011, Foresite has invested in more than 11 transformative companies spanning therapeutics, devices and diagnostics. In April of 2014, the firm announced the closing of Foresite Capital Fund II, which was oversubscribed and closed with $300 million in capital commitments. Fund II follows Foresite Capital Fund I, a $100 million fund that closed in January 2013. Foresite Capital has $2 billion in assets under management.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Amelia Stoj Chief Compliance Officer and Registered In-House Counsel
    Brett Zbar MD Managing Director
    Dennis D. Ryan MBA, CPA CFO & Managing Director
    Dorothy Margolskee MD Managing Director
    Frederick Dewey Director, Genomics Discovery


    Recent Funding Events (trailing 12 months):










      Series C







      TenSixteen Bio





      Maze Therapeutics








      Series B


    Portfolio companies include:


    Recent News: